Cargando…
Formulation and Characterization of Ursodeoxycholic Acid Nanosuspension Based on Bottom-Up Technology and Box–Behnken Design Optimization
Background: Ursodeoxycholic acid (UDCA) is a therapeutic agent used for the treatment of cholestatic hepatobiliary diseases in pediatric patients. It is a bile acid that presents high lipophilicity, and it belongs to Class II of the Biopharmaceutical Classification System (BCS), which exhibits low w...
Autores principales: | Boscolo, Oriana, Flor, Sabrina, Salvo, Leandro, Dobrecky, Cecilia, Höcht, Christian, Tripodi, Valeria, Moretton, Marcela, Lucangioli, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458560/ https://www.ncbi.nlm.nih.gov/pubmed/37631251 http://dx.doi.org/10.3390/pharmaceutics15082037 |
Ejemplares similares
-
Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design
por: Vittal, G Vijayaranga, et al.
Publicado: (2012) -
Formulation and Optimization of Oral Mucoadhesive Patches of Myrtus Communis by Box Behnken Design
por: Hashemi, Mahbubeh, et al.
Publicado: (2017) -
Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design
por: Soroush, Hadis, et al.
Publicado: (2018) -
Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design
por: Emami, J., et al.
Publicado: (2015) -
Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design
por: Gajra, Balaram, et al.
Publicado: (2015)